9th Annual Navigational Bronchoscopy Summit : Targeted Diagnostics and Targeted Therapeutics

Use of bronchoscopy as a diagnostic and therapeutic tool for lung cancer has been expanding. Recent technological advances, including navigational bronchoscopy, have increased practitioners’ ability to diagnose lung cancer at early stages, dramatically increasing the potential long-term outcomes. However, not all have the skills and knowledge to appropriately use these technologies.

To address these educational needs, this CME-certified Summit will focus on targeted diagnostics and therapeutics of lung cancer. Specific topics include lung nodule evaluation, novel invasive therapeutics for lung cancer, and targeted diagnostics of lung lesions.